Delivery Order SPE2DB20D1100-SPE2DB24FC7H4
Award Date 7/15/24
Potential Completion Date 7/16/24
Potential Value $4.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 20 mg dextroamphetamine-amphetamine capsules, a medication used to treat conditions such as ADHD. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $2,339.35 and a period of performance through May 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
- This federal contract award is for the delivery of 4559477184 units of 10mg dextroamphetamine tablets, with a ceiling value of $3,178.93. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 30, 2022, with a planned completion date of January 3, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999...
- This federal contract award is for the delivery of 4,568,506,769 tablets of dextroamphetamine-amphetamine 20 mg to the Defense Logistics Agency (DLA), a defense agency. The contract has a firm fixed price, with a ceiling value of $1,734.15, and a completion date of June 11, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and is awarded as a delivery order. Amerisourcebergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,724,223 dextroamphetamine 20 mg tablets in packages of 30. The fixed-price delivery order, valued at $1,080.66, has a completion date of September 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,379.38 firm-fixed-price contract is for the delivery of 4,566,357,650 units of 5 mg dextroamphetamine-amphetamine tablets, which will be completed by November 7, 2024. The award is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award, solicited and awarded by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,274.86 firm-fixed-price delivery order contract covers the provision of 4,566,975,300 units of dextroamphetamine-amphetamine 10 mg tablets. The contract has an ultimate completion date of January 21, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This federal contract award is for the delivery of 100-count bottles of 10mg dextroamphetamine-amphetamine tablets to the Defense Logistics Agency (DLA), a defense agency. The $2,958.12 firm fixed-price contract was awarded to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The contract has an ultimate completion date of August 9, 2024, and was awarded on August 8, 2024. This appears to be a delivery order under a larger Indefinite Delivery...
- This federal contract award is for the delivery of Dextroamphetamine-Amphetamine 5 mg tablets in 100-count bottles. The $1,033.77 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of July 10, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of 100 units of 5 mg dextroamphetamine-amphetamine tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,620.22, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that has extensive experience supplying medical products and medications to various government agencies, including the Department of Defense and the Department of Veterans Affairs. The contract does not have a set-aside...
- This federal contract award is for the delivery of 15 mg dextroamphetamine-amphetamine capsules, with a ceiling value of $1,293.75. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of December 19, 2024. The contract is not designated with a set-aside...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FC7H4Delivery Order
This federal contract award is for the delivery of 10 mg tablets of the medication dextroamphetamine-amphetamine, with a ceiling value of $4,099.20. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.
Generated 10/14/24, 9:58 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 7/15/24 |